We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
COVID-19 RSS Feed RSS

Emergent Hid Quality Problems With COVID-19 Vaccines, New Report Shows

May 12, 2022
The troubled manufacturing plant Emergent BioSolutions concealed proof of quality problems at its Baltimore, Md., location just a month and a half before it told the FDA that 15 million COVID-19 vaccine doses manufactured there had been contaminated. Read More

FDA Provides Update on Mesa Biotech’s Recall of Its Accula COVID-19 Tests

May 12, 2022
False positive results could lead to further exposure of uninfected individuals to the SARS-CoV-2 virus, the agency said. Read More

UK Study Shows Promising Data for Fourth COVID-19 Vaccine Shot

May 11, 2022
The UK currently permits people over age 75 and people who are immunosuppressed to get the fourth COVID-19 vaccine shot. Read More

FDA Open to Less Than 50 Percent Efficacy in COVID Vaccines for Smallest Kids

May 10, 2022
In a May 6 briefing before Congress, the director of the FDA’s Center of Biologics Evaluation and Research (CBER), Peter Marks, said the agency would not withhold authorization for a pediatric vaccine solely because it did not reach a 50 percent efficacy threshold at blocking symptomatic infection — a requirement that had been previously listed in FDA guidance. Read More

French Regulatory Agency to File Criminal Charges Against Didier Raoult-Led Institute

May 10, 2022
Raoult denied the gravity of the IHU’s practices. Read More

Rhinostics’ Automated Nasal Swab for COVID-19 Testing Approved by Health Canada

May 10, 2022
The swabs work with a variety of automated decappers to create hands-free workflows. Read More

Recall of Skippack Medical’s Unapproved COVID-19 Test Designated Class 1 by FDA

May 10, 2022
No false positive or negative test results were reported, the company said. Read More

WHO Recommends Veklury for COVID-19 Patients at High Risk

May 9, 2022
The WHO previously advised against using Veklury for any COVID-19 patients, regardless of disease severity. Read More

UC Researchers Examine Effects of Pfizer’s Paxlovid on ‘Long COVID’ Patients

May 9, 2022
The research paper has not yet been peer-reviewed. Read More

FDA Limits Use of J&J’s COVID-19 Vaccine

May 6, 2022
Citing the risk of rare blood clots, the FDA announced late yesterday that it is limiting the Emergency Use Authorization (EUA) for the Johnson & Johnson/Janssen COVID-19 vaccine to certain individuals. Read More

FDA Counters Pfizer’s CEO on Second Paxlovid Course After Rebound

May 6, 2022
One day after Pfizer CEO Albert Bourla said physicians could prescribe a second course of the company’s oral COVID-19 treatment Paxlovid to patients who suffer a rebound, the FDA refuted the executive’s statement. Read More

Composition for COVID-19 Vaccine for 2022-2023 Season Must be Decided by June, Say Califf, Woodcock and Marks in JAMA Editorial

May 5, 2022
A decision on the composition of a COVID-19 vaccine to be administered to the American population beginning this fall will need to be made by June. Read More
Previous 1 2 3 4 5 6 7 8 9 … 167 168 Next

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 13Jul

    FDA Ad and Promo Enforcement Trends: Past, Present and Future

  • 28Jul

    EU-MDR’s Growing Pains: Are You Current with the Latest Developments?

  • 28Jul

    Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does

  • 02Aug

    Medical Device Cybersecurity: Understand the Latest Developments

  • 03Aug

    Pharmaceutical Process Validation: Best Practices for Success

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Okami Medical’s LOBO-7 and LOBO-9 Vascular Occluders Cleared

  • FDA Puts Clinical Hold on Astellas Late-Onset Pompe Disease Clinical Trial

  • FDA Provides Update on GE Healthcare’s Recall of Its Carescape R860 Ventilators

  • Gilead Resubmits NDA for Lenacapavir Following Complete Response Letter

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing